2-(Methylthio)imidazole - CAS 7666-04-8
Catalog: |
BB035665 |
Product Name: |
2-(Methylthio)imidazole |
CAS: |
7666-04-8 |
Synonyms: |
2-(methylthio)-1H-imidazole; 2-methylsulfanyl-1H-imidazole |
IUPAC Name: | 2-methylsulfanyl-1H-imidazole |
Description: | 2-(Methylthio)imidazole (CAS# 7666-04-8) is used as a reagent in the synthesis of 4-Methyl-5-phenyl-(1,2,4)-triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type I (11β-HSD1). |
Molecular Weight: | 114.17 |
Molecular Formula: | C4H6N2S |
Canonical SMILES: | CSC1=NC=CN1 |
InChI: | InChI=1S/C4H6N2S/c1-7-4-5-2-3-6-4/h2-3H,1H3,(H,5,6) |
InChI Key: | SVOCLWUDDWXHFW-UHFFFAOYSA-N |
LogP: | 1.13160 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-112691196-A | Anti-cancer composition containing auranofin and sulfhydryl compound and application thereof | 20201230 |
CN-112425690-A | Method for inducing male transformation of fugu rubripes fries | 20201221 |
CN-111939118-A | Pharmacosome for treating hyperthyroidism in response to GSH concentration and preparation method | 20200827 |
CN-111991371-A | Pharmacosome hydrogel patch for treating hyperthyroidism in response to GSH concentration and preparation method thereof | 20200827 |
WO-2021055612-A1 | Substituted imidazole carboxamides and their use in the treatment of medical disorders | 20190917 |
PMID | Publication Date | Title | Journal |
21303950 | 20110401 | Lack of action of exogenously administered T3 on the fetal rat brain despite expression of the monocarboxylate transporter 8 | Endocrinology |
20825298 | 20100901 | Biochemical changes during goiter induction by methylmercaptoimidazol and inhibition by delta-iodolactone in rat | Thyroid : official journal of the American Thyroid Association |
20107044 | 20100401 | Posttranscriptional regulation of sodium-iodide symporter mRNA expression in the rat thyroid gland by acute iodide administration | American journal of physiology. Cell physiology |
19479014 | 20090501 | Competitive inhibition of thyroidal uptake of dietary iodide by perchlorate does not describe perturbations in rat serum total T4 and TSH | Environmental health perspectives |
16280031 | 20051201 | Dopamine D(2)-like receptor function is converted from excitatory to inhibitory by thyroxine in the developmental hippocampus | Journal of neuroendocrinology |
Complexity: | 57.7 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 114.02516937 |
Formal Charge: | 0 |
Heavy Atom Count: | 7 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 114.02516937 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 54 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 0.9 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Imidazoles
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS